Urology · 2008
Metabolic syndrome in men with Klinefelter's syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ishikawa Tomomoto, Yamaguchi Kohei, Kondo Yutaka, Takenaka Atsushi, Fujisawa Masato
Аннотация
OBJECTIVES: To investigate the metabolic syndrome and sex hormones in patients with Klinefelter's syndrome (KFS), 46XY men with nonobstructive azoospermia (NOA), and an age-matched obstructive azoospermia (OA) group.
METHODS: We examined 60 patients with KFS, 60 46XY male patients with NOA, and 50 patients with OA. Height, weight, waist circumference, and blood pressure were examined. Fasting blood samples were analyzed for sex hormones, total cholesterol, high-density lipoprotein and low-density lipoprotein cholesterol, triglycerides, and plasma glucose.
RESULTS: Height, weight, and waist circumferences were significantly greater in KFS patients compared with NOA and OA patients. Low-density lipoprotein cholesterol of KFS patients (132.9 +/- 29.4 mg/dL) was significantly increased compared with NOA (117.0 +/- 27.8 mg/dL) and OA patients (106.1 +/- 27.9 mg/dL) (P <0.05 and P <0.01). High-density lipoprotein cholesterol was significantly decreased in KFS patients (50.1 +/- 15.9 mg/dL) compared with NOA (58.7 +/- 11.7 mg/dL) and OA patients (59.5 +/- 17.9 mg/dL) (both P <0.05). Total cholesterol, triglycerides, and fasting glucose were not significantly different among the three groups. The differences between KFS and NOA, KFS and OA, and NOA and OA were all significant (P <0.01, P <0.001, and P <0.01, respectively) in terms of follicle-stimulating hormone, luteinizing hormone, and free testosterone level.
CONCLUSIONS: Hypogonadism in KFS may cause an unfavorable change in body composition and the metabolic syndrome.
METHODS: We examined 60 patients with KFS, 60 46XY male patients with NOA, and 50 patients with OA. Height, weight, waist circumference, and blood pressure were examined. Fasting blood samples were analyzed for sex hormones, total cholesterol, high-density lipoprotein and low-density lipoprotein cholesterol, triglycerides, and plasma glucose.
RESULTS: Height, weight, and waist circumferences were significantly greater in KFS patients compared with NOA and OA patients. Low-density lipoprotein cholesterol of KFS patients (132.9 +/- 29.4 mg/dL) was significantly increased compared with NOA (117.0 +/- 27.8 mg/dL) and OA patients (106.1 +/- 27.9 mg/dL) (P <0.05 and P <0.01). High-density lipoprotein cholesterol was significantly decreased in KFS patients (50.1 +/- 15.9 mg/dL) compared with NOA (58.7 +/- 11.7 mg/dL) and OA patients (59.5 +/- 17.9 mg/dL) (both P <0.05). Total cholesterol, triglycerides, and fasting glucose were not significantly different among the three groups. The differences between KFS and NOA, KFS and OA, and NOA and OA were all significant (P <0.01, P <0.001, and P <0.01, respectively) in terms of follicle-stimulating hormone, luteinizing hormone, and free testosterone level.
CONCLUSIONS: Hypogonadism in KFS may cause an unfavorable change in body composition and the metabolic syndrome.